GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » EV-to-Revenue

Abbott Laboratories (Pakistan) (KAR:ABOT) EV-to-Revenue : 1.08 (As of May. 17, 2024)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Abbott Laboratories (Pakistan)'s enterprise value is ₨62,185 Mil. Abbott Laboratories (Pakistan)'s Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₨57,698 Mil. Therefore, Abbott Laboratories (Pakistan)'s EV-to-Revenue for today is 1.08.

The historical rank and industry rank for Abbott Laboratories (Pakistan)'s EV-to-Revenue or its related term are showing as below:

KAR:ABOT' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.52   Med: 2.03   Max: 4.23
Current: 1.08

During the past 13 years, the highest EV-to-Revenue of Abbott Laboratories (Pakistan) was 4.23. The lowest was 0.52. And the median was 2.03.

KAR:ABOT's EV-to-Revenue is ranked better than
77.58% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.415 vs KAR:ABOT: 1.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-17), Abbott Laboratories (Pakistan)'s stock price is ₨668.49. Abbott Laboratories (Pakistan)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₨593.22. Therefore, Abbott Laboratories (Pakistan)'s PS Ratio for today is 1.13.


Abbott Laboratories (Pakistan) EV-to-Revenue Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) EV-to-Revenue Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.37 1.91 1.45 0.75 0.72

Abbott Laboratories (Pakistan) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.63 0.57 0.72 0.76

Competitive Comparison of Abbott Laboratories (Pakistan)'s EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan)'s EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s EV-to-Revenue falls into.



Abbott Laboratories (Pakistan) EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Abbott Laboratories (Pakistan)'s EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=62185.372/57698.28
=1.08

Abbott Laboratories (Pakistan)'s current Enterprise Value is ₨62,185 Mil.
Abbott Laboratories (Pakistan)'s Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨57,698 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories (Pakistan)  (KAR:ABOT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Abbott Laboratories (Pakistan)'s PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=668.49/593.223
=1.13

Abbott Laboratories (Pakistan)'s share price for today is ₨668.49.
Abbott Laboratories (Pakistan)'s Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨593.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories (Pakistan) EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines